A strategic advisor and investor, Dr. Ari Kellen draws on more than three decades of experience in the healthcare industry that includes practicing medicine and overseeing hospital operations. Over the course of the last three years, he has leveraged his experience to advise groundbreaking healthcare companies in the United States and beyond. In this capacity, Dr. Ari Kellen maintains a seat on the board of such entities as the biotechnology company Vaxil Bio Therapeutics and Theraclion. In 2018, he became a strategic advisor to the Israeli-based BioNanoSim, which leverages nanotechnology toward drug delivery. Concurrently, he serves as an advisor at Nouri Life, which develops solutions to strengthen the immune system.
Dr. Kellen prepared for his career with a bachelor of medicine, bachelor of surgery (MBBCh) from the University of Witwatersrand in Johannesburg, South Africa. He returned to the university to study business, obtaining his master of business administration with distinction.
